The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe

In Europe, antimicrobial resistance has been monitored since 1998 by the European Antimicrobial Resistance Surveillance System (EARSS). We examined the relationship between penicillin nonsusceptibility of invasive isolates of Streptococcus pneumoniae (an indicator organism) and antibiotic sales. Information was collected on 1998-99 resistance data for invasive isolates of S. pneumoniae to penicillin, based on surveillance data from EARSS and on outpatient sales during 1997 for beta-lactam antibiotics and macrolides. Our results show that in Europe antimicrobial resistance is correlated with use of beta-lactam antibiotics and macrolides.

[1]  U. Buchholz,et al.  Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS) , 2002, The Journal of antimicrobial chemotherapy.

[2]  J. Ioannidis,et al.  Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: a randomized trial. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  O. Cars,et al.  Variation in antibiotic use in the European Union , 2001, The Lancet.

[4]  G. Jönsson,et al.  Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. , 2000, The Pediatric infectious disease journal.

[5]  N. Nagelkerke,et al.  Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands. , 2000, The Journal of antimicrobial chemotherapy.

[6]  J. Degener,et al.  Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS). , 2000, Clinical Microbiology and Infection.

[7]  K. Kristinsson.  Modification of prescribers' behavior: the Icelandic approach. , 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  R. Gaynes,et al.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Anderson,et al.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Rossi,et al.  Risk Factors and Course of Illness Among Children With Invasive Penicillin-resistant Streptococcus pneumoniae , 1999 .

[11]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[12]  J. D. Williams.  1996 Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  Y. Chabbert.  Why a National Committee? , 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  G. Stefánsdóttir,et al.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study , 1996, BMJ.

[15]  A. Branthwaite,et al.  Pan-European Survey of Patients' Attitudes to Antibiotics and Antibiotic Use , 1996, The Journal of international medical research.

[16]  J Stephenson,et al.  Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. , 1996, JAMA.

[17]  J. Garau,et al.  Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  S. Kaplan,et al.  Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. , 1993, Pediatrics.

[19]  J. Hermans,et al.  Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci. , 1990, Journal of Antimicrobial Chemotherapy.

[20]  L. Cabero,et al.  Prevention of group B streptococcal neonatal disease: a plea for a European consensus. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  O. Cars,et al.  Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). , 1999, Scandinavian journal of infectious diseases.

[22]  A. Rossi,et al.  Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. , 1999, Pediatrics.

[23]  M. Vaara,et al.  Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. , 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.